Additionally, plasma CRP, IL-6, and lipoprotein-associated phospholipase A2 levels were significantly higher in diabetes patients with MCI compared to T2DM controls without MCI [150,151]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.